Ac-DEVD-CHO

CAS No. 169332-60-9

Ac-DEVD-CHO( —— )

Catalog No. M37941 CAS No. 169332-60-9

Ac-DEVD-CHO is a specific Caspase-3 inhibitor (Ki: 230 pM) with inhibitory effects on SLNT-induced apoptosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 188 In Stock
10MG 281 In Stock
25MG 493 In Stock
50MG 687 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ac-DEVD-CHO
  • Note
    Research use only, not for human use.
  • Brief Description
    Ac-DEVD-CHO is a specific Caspase-3 inhibitor (Ki: 230 pM) with inhibitory effects on SLNT-induced apoptosis.
  • Description
    Ac-DEVD-CHO is a specific Caspase-3 inhibitor with a Ki value of 230 pM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis | Caspase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    169332-60-9
  • Formula Weight
    502.47
  • Molecular Formula
    C20H30N4O11
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : ≥ 50 mg/mL (99.51 mM)
  • SMILES
    [H][C@@](CC(O)=O)(NC(=O)[C@@]([H])(NC(=O)[C@]([H])(CCC(O)=O)NC(=O)[C@]([H])(CC(O)=O)NC(C)=O)C(C)C)C=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Garcia-Calvo M, et al.nhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem.1998 Dec 4;273(49):32608-13.?
molnova catalog
related products
  • Deferasirox (Fe3+ ch...

    Deferasirox (Fe3+ chelate) is an orally available iron chelator with potential anticancer activity, inhibits the anti-apoptotic activity of MCL-1, and can be used to study iron overload.

  • DB1976

    DB1976 is a selenophene analog of DB270 and a highly potent, cell-permeable, fully efficacious transcription factor PU.1 inhibitor.

  • Batabulin

    Batabulin is an antitumor compound, which binds covalently and selectively to a subset of the β-tubulin isotypes, thereby disrupting microtubule polymerization.